Displaying items by tag: Concurrent Session

3:30 – 4:30 pm Thursday, August 17

A Sustainable Community Engagement Program Model to Address Hematopoietic Cell Transplantation Education Needs for Patients with Sickle Cell Disease (201)

1CH  Sickle cell disease (SCD) has often been called the “ultimate orphan disease” in the United States. The hemoglobin disorder affects nearly 100,000 people, yet in the 100 years since its discovery, there has only been one U.S. Food and Drug Administration–approved drug. Recent advances in treatment have shown that hematopoietic cell transplantation (HCT) offers a possible cure. Yet, this therapeutic modality is significantly underutilized and lack of access to patient-centered HCT information remains a major barrier.

Read more...
2 – 3 pm Saturday, August 19

Leveraging Smartphones to Capture Symptoms During Advanced Cancer: Integrating an Innovative Idea Into A Grant-Funded Research Study (233)

1CH  Pediatric oncology nurses have an interest in developing research studies to address gaps in knowledge and improve patient care. Furthermore, nurses have identified smartphone technology as a potential tool for symptom assessment research. The purpose of this presentation is to discuss the development of a research protocol based on a single innovative idea, review of the status of this active research study, and provide education related to the use of technology in nursing research.

Read more...
2 – 3 pm Saturday, August 19

Expanding Your Educational Horizons – DNP or PhD? (232)

1CH  The commitment to a career focused on practice or research is one of the first decisions pediatric hematology/oncology nurses must make when considering advanced educational preparation and choosing between a Doctor of Nursing Practice (DNP) and a Doctor of Nursing Science/Philosophy (PhD) program. 

Read more...
2 – 3 pm Saturday, August 19

A Sustainable Community Engagement Program Model to Address Hematopoietic Cell Transplantation Education Needs for Patients with Sickle Cell Disease (231)

1CH  Sickle cell disease (SCD) has often been called the “ultimate orphan disease” in the United States. The hemoglobin disorder affects nearly 100,000 people, yet in the 100 years since its discovery, there has only been one U.S. Food and Drug Administration–approved drug. Recent advances in treatment have shown that hematopoietic cell transplantation (HCT) offers a possible cure. 

Read more...
11:30 am – 12:30 pm Saturday, August 19

Playing on Our Strengths – Developing Interprofessional Teams in Pediatric Hematology/Oncology (227)

1CH  The care of pediatric hematology/oncology patients requires a diverse team of healthcare professionals. Interprofessional collaboration between these disciplines improves coordination of care, communication, and patient safety. However, the “how-to” of interprofessional team development is infrequently incorporated in healthcare professional training programs.

Read more...
11:30 am – 12:30 pm Saturday, August 19

Baseline Standards for Pediatric Oncology Nursing in Low and Mid Income Countries (226)

1CH  Approximately 80% of children with cancer live in low and mid-income countries, where survival rates are as low as 20%. These dismal outcomes are in sharp contrast with the remarkable improvements in survival noted in children who live in high-income countries. Nurses are crucial to the provision of quality pediatric oncology care, yet many nurses worldwide lack the essential education, support, and resources needed to reach their potential.

In response, baseline global standards for pediatric oncology nursing were published in 2014. The standards outline essential components of a quality nursing program, including safe staffing levels, formalized orientation and ongoing education, acknowledgment of nurses as core team members, available resources for safe care, and policies to drive evidence-based care.

Read more...
Subscribe to this RSS feed